Business Context and Reporting Period
This Form 6-K filing by Innate Pharma S.A. covers the month of April 2023, with a report date of April 6, 2023. The registrant is a foreign private issuer based in Marseille, France, and files annual reports under Form 20-F.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a vehicle to submit a press release (Exhibit 99.1) rather than a financial statement.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data is included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the cover page and signature block referencing an attached press release.
Investor Verification Checklist
- Review the attached Press Release (Exhibit 99.1) for the specific corporate announcement triggering this filing.
- Verify the date of the press release to ensure it aligns with the April 6, 2023, report date.
- Check subsequent filings for any financial impact resulting from the announcement made in the press release.